Replies to post #63269 on Nutra Pharma Corp (NPHC)

[Brokemillwright]

Mark it like where you said CE off within a week??

[Brokemillwright]

This didn't age well

[I-Glow]

You were pumping since 2009 - and spewing nonsense about NPHC being shorted even when the price was $0.0001 - proving you were clueless about shorting.

You posted many times that Deitsch kicked the SEC'S ass and that didn't work out very well.

Now NPHC is on the Expert Market market and you have lost your entire investment.

"Not a chance nphc goes to gray market. They filed their 10q. They dont have any outstanding financial filings. just absurd to even think that they would go to gray. mark this post."

The Expert Market is the new Grey market.

Here is something you posted dozens of times and I always got a good laugh.

""cngreen
Friday, 07/16/2021 3:48:03 PM

Here is what's coming from Deitsch and NPHC

Multiple Sclerosis Trials

Government Grants for validation of NPHC Nerve Agent Counter measure

Adding to NPHC's 21 Patents

Additional Social Media Endorsements

New Products from NPHC

Here is what Deitsch the CEO has done for NPHC in 19 years:

Added Many patents and trademarks to Nutra's portfolio

Clinical Trials in Multiple Phases

1. Multiple Sclerosis Trials

2. Herpes Simplex Infections 1 & 2 Trials

3. Adrenomyeloneuropathy Trials

4. HIV Trials

5. Amyotrophic Lateral Sclerosis Trials

6. Rheumatoid Arthritis Trials

7. Pain Trials

Products launched and brought to Market

1. Cobroxin

2. Nyloxin

3. Pet Pain Away

4. Equine pain Away

5. Luxury Feet

Published Research

http://receptopharm.com/drug_development/published_research.php
https://www.nutrapharma.com/research

Increased Sales on Amazon and Walmart

RPI-78M has received Orphan Drug Designation from the FDA for the treatment of Pediatric Multiple Sclerosis

Huge personal loans from Deitsch to NPHC tells me the CEO knows and believes in NPHC"

And you bought into all of the Deitsch BS.

Damn, I have never seen anyone as wrong as you about a stock.

IG